IMA950 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IMA950 vaccine, covering 2024-06-14 to 2024-06-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) [Phase 1]